Trial Profile
A Study to Assess the Pharmacokinetics, Tolerability and Safety of the co-Administration of Sancuso (Transdermal Granisetron) and Intravenous Granisetron in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs Granisetron (Primary) ; Granisetron (Primary)
- Indications Nausea and vomiting
- Focus Pharmacokinetics
- Sponsors ProStrakan
- 05 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 17 Apr 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.